Carrots and Stick: Biopharma At The White House
Executive Summary
Drug industry executives discuss drug pricing and tax and regulatory reform in a high-profile meeting with President Trump at the White House.
You may also be interested in...
Trump Lauds Big Pharma Collaboration On Super Strong Glass Packaging
President announces Merck, Pfizer and Corning collaboration on new glass packaging for injectable drugs as part of "Made In America Week;" says FDA is streamlining regulations.
Biotech Execs Promote Biomedical R&D At White House Meeting
At meeting led by NIH Director Collins, participants talked about importance of biomedical research and need for partnerships between industry, government and academia.
Scientists Marched To Protect NIH Grants, But Where Was Pharma?
Funding from the US National Institutes of Health is a vital source for biomedical research and pharmaceutical pipelines in turn – but biopharma companies have been largely silent on the matter.